Largo
PRTK - Bulls Almost Hit The Target...

Paratek Pharmaceuticals, Inc. engages in the development and commercialization of therapies based upon tetracycline chemistry. Its products include omadacycline and sarecycline, which are used for the treatment of community-acquired bacterial infections, including community-acquired bacterial pneumonia, acute bacterial skin and skin structure infections and urinary tract infections. The company was founded by Walter Gilbert and Stuart B. Levy in 1996 and is headquartered in Boston, MA.
SHORT INTEREST
10.98M 08/15/19
P/E Current
-1.09
P/E Ratio (with extraordinary items)
-1.02
Average Recommendation: BUY
Average Target Price: 21.33
SHORT INTEREST
10.98M 08/15/19
P/E Current
-1.09
P/E Ratio (with extraordinary items)
-1.02
Average Recommendation: BUY
Average Target Price: 21.33
Exención de responsabilidad
La información y las publicaciones no constituyen, ni deben considerarse como, asesoramiento o recomendaciones financieras, de inversión, de trading u otro tipo, proporcionadas o respaldadas por TradingView. Obtenga más información en Condiciones de uso.
Exención de responsabilidad
La información y las publicaciones no constituyen, ni deben considerarse como, asesoramiento o recomendaciones financieras, de inversión, de trading u otro tipo, proporcionadas o respaldadas por TradingView. Obtenga más información en Condiciones de uso.